Baukelien van Triest

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin et al. · The Lancet Oncology · 2018 · 623 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin et al. · The Lancet Oncology · 2019 · 456 citations · Full text

Medicine, Gynecology, Oncology +17

Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy

Bastiaan G. Wortman, Carien L. Creutzberg, Hein Putter et al. · British Journal of Cancer · 2018 · 282 citations · Full text

Medicine, Oncology, Radiation Oncology +15

A Multi-institutional Clinical Trial of Rectal Dose Reduction via Injected Polyethylene-Glycol Hydrogel During Intensity Modulated Radiation Therapy for Prostate Cancer: Analysis of Dosimetric Outcomes

Danny Y. Song, Klaus Herfarth, Matthias Uhl et al. · International Journal of Radiation Oncology*Biology*Physics · 2013 · 152 citations

Medicine, Oncology, Radiation Oncology +17

The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy

Sophie R. de Mol van Otterloo, John P. Christodouleas, Erwin L. A. Blezer et al. · Frontiers in Oncology · 2020 · 151 citations · Full text

Medicine, Radiation Oncology, Radiology +17